Tag
#Semaglutide
Explore articles tagged with Semaglutide
Media Coverage
Indian API Makers Gear Up for Semaglutide Demand
HRV Pharma's CEO discusses Indian API manufacturers' strategic preparation for semaglutide demand as Ozempic patent expiry approaches, with extensive global media coverage.
Industry News
GLP-1 Patent Expiry 2026: A Defining Opportunity for Indian Pharma
HRV Pharma's CEO Hari Kiran Chereddi analyzes India's strategic opportunity in GLP-1 drug manufacturing as Semaglutide patents expire in 2026, emphasizing the shift from reverse engineering to innovative design.